GE HealthCare Technologies GEHC
NASDAQ GEHC
$74.05 -0.57 (-0.76%)
As of: Aug 20, 2026 · 3:59 PM EDT

GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Cash from Investing Activities came in at -$115.0 million in Q2 2026, up 48.43% YoY from -$77.5 million in Q2 2025, and up 95.4% on a QoQ basis from -$2.5 billion in Q1 2026.

GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Cash from Investing Activities data on file, last reported at -$115.0 million in Q2 2026.

  • Quarterly Cash from Investing Activities rose 48.43% year-over-year to -$115.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.0 billion (down 201.09% YoY) and the FY2025 annual result came in at -$1.0 billion, down 14.55% from the prior year.
  • Cash from Investing Activities advanced to -$115.0 million in Q2 2026, from -$2.5 billion in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$84.0 million in Q2 2023 to a low of -$2.5 billion in Q1 2026.
  • A 5-year average of -$307.3 million and a median of -$142.5 million in 2024 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 48.43% in 2026, down 514.25% in 2026.
  • Tracing GEHC's Cash from Investing Activities over 5 years: stood at -$95.0 million in 2022, then grew by 7.37% to -$88.0 million in 2023, then tumbled by 172.73% to -$240.0 million in 2024, then dropped by 12.08% to -$269.0 million in 2025, then soared by 57.25% to -$115.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$115.0 million (Q2 2026), -$2.5 billion (Q1 2026), and -$269.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -673.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -22.08 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -108.50 Mn
10 Zimmer Biomet Holdings 19.04 Bn 18.63 Bn 1.54 Bn -190.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -115.00 Mn
Jun 30, 2026 -115.00 Mn
Mar 31, 2026 -2.50 Bn
Mar 31, 2026 -2.50 Bn
Dec 31, 2025 -269.00 Mn
Dec 31, 2025 -269.00 Mn
Sep 30, 2025 -148.00 Mn
Sep 30, 2025 -148.00 Mn
Jun 30, 2025 -223.00 Mn
Jun 30, 2025 -223.00 Mn
Mar 31, 2025 -407.00 Mn
Mar 31, 2025 -407.00 Mn
Dec 31, 2024 -240.00 Mn
Dec 31, 2024 -240.00 Mn
Sep 30, 2024 -137.00 Mn
Sep 30, 2024 -137.00 Mn
Jun 30, 2024 -349.00 Mn
Jun 30, 2024 -349.00 Mn
Mar 31, 2024 -188.00 Mn
Mar 31, 2024 -188.00 Mn